DOSSIER · UPDATED 18 NOV 2025

Actym Therapeutics

Actym Therapeutics, based in Berkeley, CA, is a privately-held biotechnology company focused on discovery and development of novel immuno-oncology therapies to treat cancer. The company has developed an attenuated, microbial-based,…

actymthera.com ↗Claim this profile

Founded: 2017
Headcount: 19
Open roles: 0
Last raised: Series A · $26M

SECTION I · THE BRIEF

Inside Actym Therapeutics

Brief #45820Updated 18 NOV 2025BERKELEYMEDICAL ORGANIZATIONSSERIES A

Employbl Dossier

Actym Therapeutics

Founded: 2017
Headcount: 19
Open roles: 0
Last raised: Series A · $26M

Section II · Premium ProfileMembers only

01Engineering interview process at Actym TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Actym Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Laura Hix Glickman

President at Immunitas Consulting

Immunitas ConsultingActym TherapeuticsAduro Biotech is now Chinook TherapeuticsCatalyst BiosciencesHawaii BiotechUCSFFeinberg School of MedicineUniversity Of HawaiiUC Berkeley

Christopher Thanos

CEO at Actym Therapeutics

Actym TherapeuticsHalozyme TherapeuticsSutro BiopharmaCatalyst BiosciencesSunesis PharmaceuticalsUCLA

OPEN ROLES

Hiring at Actym Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $59,500,000

Actym Therapeutics Funding Rounds

Series A
$25,500,000
Oct 18, 2023
Series A
$25,500,000
Oct 17, 2023
Series A Investors
Boehringer Ingelheim Venture Fund
Illumina Ventures
GKCC
JLo Ventures
Panacea Venture
Series A
$34,000,000
Apr 27, 2020
Series A
$34,000,000
Apr 26, 2020
Series A Investors
Boehringer Ingelheim Venture Fund
Panacea Venture
JLo Ventures
Illumina Ventures
Korea Investment Partners